scholarly journals Endoscopic therapy of the YAG laser in early stage stomach cancer of protruded tgpe and gastric polyp.

1980 ◽  
Vol 1 (1) ◽  
pp. 400-402
Author(s):  
K. Mizushima ◽  
K. Harada ◽  
M. Namiki ◽  
S. Kasai ◽  
M. Mito
1969 ◽  
Vol 4 (3) ◽  
pp. 237-237
Author(s):  
H. Kuramata ◽  
T. Hataya ◽  
F. Unayama ◽  
S. Eto ◽  
A. Tsuboi ◽  
...  

Lung Cancer ◽  
2001 ◽  
Vol 31 (1) ◽  
pp. 31-36 ◽  
Author(s):  
A.J.M van Boxem ◽  
J Westerga ◽  
B.J.W Venmans ◽  
P.E Postmus ◽  
G Sutedja

1990 ◽  
Vol 98 (5) ◽  
pp. 1239-1244 ◽  
Author(s):  
Kenneth Matthewson ◽  
C. Paul Swain ◽  
Martin Bland ◽  
J. Squire Kirkham ◽  
Stephen G. Bown ◽  
...  

2020 ◽  
Vol 08 (06) ◽  
pp. E717-E721
Author(s):  
Fadi Hawa ◽  
Zeyad Sako ◽  
Than Nguyen ◽  
Andrew T. Catanzaro ◽  
Eugene Zolotarevsky ◽  
...  

Abstract Background and study aims Endoscopic resection is recommended as initial treatment for early-stage gastric and duodenal neuroendocrine tumors (G-NETs and D-NETs). However, it can cause serious adverse events. We aimed to evaluate the efficacy and safety of the band and slough (BAS) technique as a novel and less aggressive endoscopic therapy for management of such tumors.Four patients, three diagnosed with < 10-mm D-NET and one with 10-mm type I G-NET, were treated with the BAS technique without endoscopic resection. Initial follow-up endoscopy at 3 months was done to assess for residual tumor. Subsequent endoscopic surveillance was performed. After one session of banding, all patients achieved complete remission at 3-month follow-up. No tumor recurrence was detected on repeat biopsy at 12-month surveillance endoscopy. None of the patients developed any adverse events including bleeding or perforation.The BAS technique may prove to be a safe and effective endoscopic therapy for diminutive, non-metastatic type 1 G-NETs and D-NETs. Studies of larger scale and longer follow-up periods are needed to corroborate these findings.


Haigan ◽  
1987 ◽  
Vol 27 (2) ◽  
pp. 173-180
Author(s):  
Haruhiko Nakamura ◽  
Kenkichi Oho ◽  
Osamu Taira ◽  
Tomiaki Shou ◽  
Ryuta Amemiya ◽  
...  

1995 ◽  
Vol 768 (1) ◽  
pp. 269-271 ◽  
Author(s):  
ZUO-FENG ZHANG ◽  
MARTIN S. KARPEH ◽  
GREGORY Y. LAUWERS ◽  
ARTURO M. MARRERO ◽  
DAPHNA POLLACK ◽  
...  

1986 ◽  
Vol 1 (2) ◽  
pp. 222-229 ◽  
Author(s):  
Sun Moon Cheong ◽  
Duk Jhae Sun ◽  
Kyu Sung Rim

1998 ◽  
Vol 12 (5) ◽  
pp. 355-359 ◽  
Author(s):  
Haruhiro Inoue

Accumulated data from surgically resected specimens reveal that mucosal cancers of the esophagus and stomach pose low risk of lymph node metastasis. The author used endoscopic mucosal resection (EMR) as curative treatment in 142 cases of esophageal cancer and 102 cases of stomach cancer. In absolutely indicated cases there has been no local or distant metastasis during the longest period of follow-up (nine years). One perforation and one post-treatment severe stenosis, which was resistant to dilation therapy in the esophagus, were encountered. Deeper layer resection (including partial proper muscle) occurred in the stomach in three cases where the lesions were positioned to the lesser curvature of the upper part of the stomach. Two cases of gastric mucosal resection leaving residual cancer were successfully treated by laser ablation. No case has required further surgery. Resected specimens were contributed to histological evaluation in all cases. In conclusion, EMR can be considered as the first-line treatment for selected cases of early stage esophageal and stomach cancer.


Sign in / Sign up

Export Citation Format

Share Document